Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Bukwang Pharm (003000)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6,150 0    0.00%
26/04 - Closed. Currency in KRW ( Disclaimer )
  • Volume: 68,973
  • Bid/Ask: 6,150 / 6,160
  • Day's Range: 6,110 - 6,190
Type:  Equity
Market:  South Korea
ISIN:  KR7003000007 
Bukwang Pharm 6,150 0 0.00%

003000 Balance Sheet

 
Assess the latest Bukwang Pharm balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 003000 Annual Report data, financial summaries and charts are available for Bukwang Pharm investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 254178.52 214272.94 206002.09 206785.6
Cash and Short Term Investments 151227.17 86308.94 68299.76 69795.78
Cash - - - -
Cash & Equivalents 151227.17 81308.94 68299.76 69795.78
Short Term Investments - 5000 - -
Total Receivables, Net 37376.36 59754.94 84644.61 85992.82
Accounts Receivables - Trade, Net 35729.28 58296.35 84320.15 85722.75
Total Inventory 56831.84 61646.67 46493.81 44901.48
Prepaid Expenses 166.97 219.24 256.37 104.3
Other Current Assets, Total 8576.18 6343.15 6307.54 5991.22
Total Assets 429017.05 394279.58 386874.81 385636.67
Property/Plant/Equipment, Total - Net 122788.51 123722.81 123778.23 123676.63
Property/Plant/Equipment, Total - Gross 194538.42 195732.73 194948 194094.8
Accumulated Depreciation, Total -71749.92 -72009.92 -71169.77 -70418.17
Goodwill, Net 878.73 1629.14 1629.98 1884.02
Intangibles, Net 9177.45 7947.35 7958.65 6318.61
Long Term Investments 31626.25 33305.99 33559.22 32437.17
Note Receivable - Long Term 1647.09 1458.59 324.45 270.08
Other Long Term Assets, Total 10367.58 13401.35 13946.65 14534.64
Other Assets, Total 28031.66 13234.87 -31843.26 -35100.13
Total Current Liabilities 97544.07 28130.41 33570.44 33123.72
Accounts Payable 2368.36 6873.98 10424.32 10915.08
Payable/Accrued - - - -
Accrued Expenses 2978.34 - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 217.6 244.63 302.53 350.86
Other Current liabilities, Total 91979.77 21011.8 22843.58 21857.77
Total Liabilities 194752.38 144295.93 119598.43 118465.63
Total Long Term Debt 79169.3 30555.66 600.16 637.67
Long Term Debt 78525.13 30000 - -
Capital Lease Obligations 644.17 555.66 600.16 637.67
Deferred Income Tax 10067.8 11063.71 11193.59 11576.34
Minority Interest 7953.32 6618.2 7522.85 8163.96
Other Liabilities, Total 17.89 67927.95 66711.39 64963.95
Total Equity 234264.67 249983.65 267276.39 267171.04
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 36401.99 36401.99 36401.99 36401.99
Additional Paid-In Capital 4807.87 6799.91 6799.91 6799.91
Retained Earnings (Accumulated Deficit) 225783.29 237850.37 254034.84 253102.8
Treasury Stock - Common -50784.46 -50784.46 -50784.46 -50784.46
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 18055.98 19715.83 20824.1 21650.79
Total Liabilities & Shareholders' Equity 429017.05 394279.58 386874.81 385636.67
Total Common Shares Outstanding 68.26 68.45 68.45 68.45
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

003000 Price Commentary

Write your thoughts about Bukwang Pharm
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email